Competition to get heated over fentanyl patch market

Published: 2011-06-03 07:00:00

Updated: 2011-06-03 07:00:00

Daewoong Pharmaceutical and Sandoz Korea are poised to step up their marketing in the fentanyl transdermal therapeutic systems market, which has been so far dominated by Janssen’s Durogenic.

Daewoong is expected to market Nycomed’s Matrifen of five different strengths (12, 25, 50, 75 and 100 &...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK